Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Boston Scientific (BSX)

Boston Scientific director John Sununu will not stand for re-election in 2026

Neutral Impact 2 of 5 leadership Written later

Boston Scientific director John E. Sununu told the company on October 22, 2025, that he will not stand for re-election at the 2026 Annual Meeting of Stockholders. He will remain a director and keep his committee roles until that meeting, and the company says the decision is not the result of any disagreement.

Key points

  • Sununu has served on the Board since April 2009.
  • He currently sits on the Audit Committee and chairs the Nominating and Governance Committee.
  • He will continue as a director until the 2026 Annual Meeting.
  • The Board will evaluate whether to add directors after his departure.

The filing

CompanyBoston Scientific (BSX)
Form8-K, current report
Filed with the SECOct 23, 2025, 4:21 PM ET
Accession number0000885725-25-000048

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.